Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Prevalence of genotypic resistance to nucleoside analogues and protease inhibitors in antiretroviral-naive HIV patients in Campania, Italy.

Journal of chemotherapy (Florence, Italy) - 1 Dec 2004

Filippini P, Liguori G, Scolastico C, Coppola N, Lucariello A, Marrocco C, Catania M R, Ortega De Luna L, Romano Carratelli C, Marinelli P, Sagnelli E, Rossano F

Abstract excerpt

The aim of our study was to determine the prevalence of genotypic resistance to nucleoside analogues and protease inhibitors before and after 1997, the year of introduction of Highly Active Antiretroviral Therapy (HAART) in Campania (Italy). Forty-eight plasma HIV-RNA positive patients who had not been previously treated for HIV infection (naïve) were enrolled in two Divisions of Infectious Diseases. The main...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anti-Retroviral Agents
Share to Antiretroviral Therapy, Highly Active

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Drug Resistance, Viral

Share to Epidemiologic Studies

Share to HIV Infections

Share to Protease Inhibitors

Share to Viral Load

Source

Identifiers

PMID: 15700844
DOI: 10.1179/joc.2004.16.6.534

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Prevalence of genotypic resistance to nucleoside analogues and protease inhibitors in antiretroviral-naive HIV patients in Campania, Italy.PMID 15700844Read ↗

Updated prevalence of genotypic resistance among HIV-1 positive patients naïve to antiretroviral therapy: a single center analysis.Semantic proximity Read ↗

Prevalence of genotypic resistance to nucleoside analogues and protease inhibitors in Spain. The ERASE-2 Study Group.Semantic proximity Read ↗

Prevalence of antiretroviral drug resistance in untreated persons newly diagnosed with HIV-1 infection.Semantic proximity Read ↗

Primary HIV-1 resistance in recently and chronically infected individuals of the Italian Cohort Naive for Antiretrovirals.Semantic proximity Read ↗

Prevalence of genotypic resistance to nucleoside analogues in antiretroviral-naive and antiretroviral-experienced HIV-infected patients in Spain.Semantic proximity Read ↗

Prevalence of genotypic resistance among antiretroviral drug-naive HIV-1-infected patients in Belgium.Semantic proximity Read ↗

[Prevalence of primary antiretroviral resistance among HIV infected patients in Chile].Semantic proximity Read ↗

Prevalence of genotypic resistance to nucleoside analogues in antiretroviral-naive and antiretroviral-experienced HIV-infected patients in SpainSemantic proximity Read ↗

Genotypic resistance to antiretroviral drugs in patients infected with several HIV type 1 genetic forms in Cuba.Semantic proximity Read ↗

Characterization of the patterns of drug-resistance mutations in newly diagnosed HIV-1 infected patients naïve to the antiretroviral drugs.Semantic proximity Read ↗

Prevalence of genotypic resistance to nucleoside analogues, nonnucleoside analogues, and protease inhibitors in HIV-infected persons in Athens, Greece.Semantic proximity Read ↗

Prevalence of genotypic resistance in untreated HIV-infected patients.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.